Literature DB >> 12089190

Development and evaluation of a PCR-based, line probe assay for the detection of 58 alleles in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

XinJing Wang1, Angela Myers, Randall K Saiki, Garry R Cutting.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12089190

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  11 in total

1.  CFTR mutations and reproductive outcomes in a population isolate.

Authors:  Irene Gallego Romero; Carole Ober
Journal:  Hum Genet       Date:  2007-09-28       Impact factor: 4.132

Review 2.  Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment.

Authors:  Samuel M Moskowitz; Ronald L Gibson; Eric L Effmann
Journal:  Pediatr Radiol       Date:  2005-05-03

3.  Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.

Authors:  Scott M Blackman; Rebecca Deering-Brose; Rita McWilliams; Kathleen Naughton; Barbara Coleman; Teresa Lai; Marilyn Algire; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; M Daniele Fallin; Kristen West; Dan E Arking; Aravinda Chakravarti; David J Cutler; Garry R Cutting
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

4.  Heritability of lung disease severity in cystic fibrosis.

Authors:  Lori L Vanscoy; Scott M Blackman; Joseph M Collaco; Amanda Bowers; Teresa Lai; Kathleen Naughton; Marilyn Algire; Rita McWilliams; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; Dave Cutler; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

5.  Variants in mannose-binding lectin and tumour necrosis factor alpha affect survival in cystic fibrosis.

Authors:  Kitti Buranawuti; Michael P Boyle; Suzanne Cheng; Lori L Steiner; Kathryn McDougal; M Daniele Fallin; Christian Merlo; Pamela L Zeitlin; Beryl J Rosenstein; Peter J Mogayzel; Xinjing Wang; Garry R Cutting
Journal:  J Med Genet       Date:  2006-12-11       Impact factor: 6.318

6.  Alcohol consumption and breast tumor mitochondrial DNA mutations.

Authors:  Mary E Platek; Peter G Shields; Duanjun Tan; Catalin Marian; Matthew R Bonner; Susan E McCann; Jing Nie; Gregory E Wilding; Christine Ambrosone; Amy E Millen; Maurizio Trevisan; Marcia Russell; Thomas H Nochajski; Stephen B Edge; Janet Winston; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2009-10-22       Impact factor: 4.872

7.  Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.

Authors:  Kathryn E McDougal; M Daniele Fallin; David R Moller; Zhimin Song; David J Cutler; Lori L Steiner; Garry R Cutting
Journal:  J Invest Dermatol       Date:  2009-02-19       Impact factor: 8.551

8.  Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis.

Authors:  Kathryn E McDougal; Deanna M Green; Lori L Vanscoy; M Daniele Fallin; Michael Grow; Suzanne Cheng; Scott M Blackman; J Michael Collaco; Lindsay B Henderson; Kathleen Naughton; Garry R Cutting
Journal:  Eur J Hum Genet       Date:  2010-01-13       Impact factor: 4.246

9.  Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

Authors:  Lindsay B Henderson; Vishal K Doshi; Scott M Blackman; Kathleen M Naughton; Rhonda G Pace; Jackob Moskovitz; Michael R Knowles; Peter R Durie; Mitchell L Drumm; Garry R Cutting
Journal:  PLoS Genet       Date:  2012-03-15       Impact factor: 5.917

Review 10.  Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders.

Authors:  Samuel M Moskowitz; James F Chmiel; Darci L Sternen; Edith Cheng; Ronald L Gibson; Susan G Marshall; Garry R Cutting
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.